Seven companies went public this past week; only one (iDreamSky, DSKY) priced above its midpoint while just one other IPO (Ryerson, RYI) ended the week negative. Broader markets remain rocky, dampening the demand for initial public offerings ahead...read more
T2 Biosystems, which is developing diagnostic tests to screen for sepsis and impaired hemostasis, raised $57 million by offering 5.2 million shares at $11, well below the $15 to $17 range. T2 Biosystems plans to list on the NASDAQ under the symbol TTOO....read more
11 offerings are scheduled to kick off the first full week of August, a month that should see a sharp slowdown in IPO activity following the busiest month since 2000 (July had 34 IPOs, ...read more
T2 Biosystems, which is developing diagnostics tests that screen for sepsis and hemostasis, announced terms for its IPO on Monday. The Lexington, MA-based company plans to raise $64 million by offering 4.0 million shares at a price range of $15 to $17. At the...read more
US IPO Pricing Recap: 7 IPOs see heavy discounts and positive trading
Seven companies went public this past week; only one (iDreamSky, DSKY) priced above its midpoint while just one other IPO (Ryerson, RYI) ended the week negative. Broader markets remain rocky, dampening the demand for initial public offerings ahead...read more
T2 Biosystems prices upsized IPO at $11, well below the range
T2 Biosystems, which is developing diagnostic tests to screen for sepsis and impaired hemostasis, raised $57 million by offering 5.2 million shares at $11, well below the $15 to $17 range. T2 Biosystems plans to list on the NASDAQ under the symbol TTOO....read more
11 US IPOs planned for the week of Aug 4
11 offerings are scheduled to kick off the first full week of August, a month that should see a sharp slowdown in IPO activity following the busiest month since 2000 (July had 34 IPOs, ...read more
Diagnostics developer T2 Biosystems sets terms for $64 million IPO
T2 Biosystems, which is developing diagnostics tests that screen for sepsis and hemostasis, announced terms for its IPO on Monday. The Lexington, MA-based company plans to raise $64 million by offering 4.0 million shares at a price range of $15 to $17. At the...read more